Angiogenesis
31
0
2
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
0%
0 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (31)
CD160 Expression in Corneal Vessels
Evaluation of Irisin Levels in Adult Forearm Fracture Surgery Under Infraclavicular Block and General Anesthesia
Interactive Hand Exercise Game on Grip Strength and Vascular Maturation
Multiple Micronutrients Supplementation on Angiogenesis and Vasculogenesis Factors, and Fetal Biometry
Angiogenic Factors in the Placentas of Women With COVID-19
The Effect of Butanediol Ingestion on Skeletal Muscle Angiogenesis in Hypoxia
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer
GnRH-a on Angiogenesis of Endometriosis
Endothelial Damage and Angiogenesis Biomarkers During COVID-19
The Role of Bleeding at Implant Placement
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
Postoperative VEGF and Recurrence After Colon Cancer Surgery
The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits